Tables
- Table 1– Selected characteristics of participants in the Taiwan Children Health Study
With genotyping All eligible participants Subjects n 3764 5082 Demographic information Males 1848 (49.1) 2464 (48.5) Age yrs 12.26±0.50 12.42±0.65 Parental education# yrs ≤12 2319 (62) 3201 (63.4) 13–15 740 (19.8) 964 (19.1) ≥16 679 (18.2) 884 (17.5) Gestational age# ≤37 335 (9.1) 461 (9.3) >37 3342 (90.9) 4496 (90.7) Parental asthma# 114 (3.1) 140 (2.9) Parental atopy# 957 (26.4) 1263 (25.8) Family income# TWD ≤400000 1249 (35.8) 1777 (37.7) 400001–800000 1408 (40.4) 1853 (39.3) ≥810000 828 (23.8) 1080 (22.9) Active smoking# 26 (0.7) 37 (0.7) Maternal smoking during pregnancy# 146 (3.9) 198 (3.9) ETS at home# 1774 (47.4) 2471 (48.9) Incense burning at home# Never 1326 (37.0) 1724 (35.8) Less than daily 1021 (28.5) 1398 (29.0) Daily 1237 (34.5) 1699 (35.2) Respiratory outcomes# Asthma Lifetime asthma 292 (7.8) 375 (7.4) Current asthma 114 (3.1) 140 (2.9) Medication use 96 (2.6) 123 (2.4) Wheeze Lifetime wheeze 449 (12.0) 586 (11.6) Current wheeze 150 (4.0) 186 (3.7) Nocturnal wheeze 82 (2.2) 109 (2.2) Exercise wheeze 206 (5.5) 276 (5.5) Data are presented as n (%) or mean±sd, unless otherwise stated. TWD: New Taiwan dollar; ETS: environmental tobacco smoke. #: number of subjects does not sum to total because of missing data.
- Table 2– Effects of incense burning at home and glutathione S-transferase genotype on subcategories of asthma and wheeze
Asthma Wheeze Lifetime asthma Current asthma Medication use Lifetime wheeze Current wheeze Nocturnal wheeze Exercise wheeze Incense burning 1.05 (0.80–1.36) 1.36 (1.01–2.00) 1.52 (1.02–2.42) 1.10 (0.88–1.37) 1.07 (0.75–1.53) 1.31 (0.8–2.14) 1.64 (1.18–2.28) Frequency of incense burning# Never 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Less than daily 0.76 (0.54–1.07) 1.13 (0.70–1.83) 1.29 (0.72–2.30) 0.92 (0.70–1.21) 1.00 (0.64–1.56) 1.07 (0.58–2.01) 1.62 (1.09–2.41) Daily 1.22 (0.90–1.64) 1.52 (0.99–2.34) 1.75 (1.03–2.96) 1.21 (0.94–1.55) 1.12 (0.74–1.70) 1.68 (0.97–2.93) 1.88 (1.29–2.74) p-value for trend 0.20 0.05 0.03 0.13 0.60 0.06 0.001 GSTT1 null 1.21 (0.95–1.56) 1.43 (1.00–2.04) 1.46 (1.01–2.22) 1.17 (0.95–1.44) 1.14 (0.81–1.60) 1.14 (0.72–1.79) 1.09 (0.81–1.47) GSTM1 null 0.87 (0.68–1.12) 0.89 (0.63–1.27) 0.84 (0.55–1.27) 0.98 (0.80–1.21) 0.91 (0.65–1.27) 0.73 (0.47–1.16) 0.90 (0.67–1.21) GSTP1Ile/Ile 1.18 (0.60–2.32) 0.89 (0.37–2.11) 0.72 (0.28–1.85) 0.96 (0.57–1.61) 0.83 (0.37–1.86) 1.21 (0.37–4) 1.76 (0.7–4.41) Data are presented as odds ratios with 95% confidence intervals. Models are adjusted for age, sex, parental education, parental asthma, parental atopy, gestational age, city, maternal smoking during pregnancy and environmental tobacco smoke at home. #: average days of incense burning at home per month.
- Table 3– Association between incense burning at home and GSTT1 genotype on subcategories of asthma and wheeze
No incense With incense GSTT1 present GSTT1 null GSTT1 present GSTT1 null Univariate model Asthma Lifetime asthma 1.00 1.12 (0.76–1.65) 0.87 (0.61–1.25) 1.11 (0.79–1.58) Current asthma# 1.00 1.37 (0.77–2.45) 1.09 (0.63–1.87) 1.56 (0.93–2.63) Medication use 1.00 1.39 (0.67–2.88) 1.25 (0.64–2.44) 1.87 (0.99–3.55) Wheeze Lifetime wheeze 1.00 1.08 (0.78–1.48) 0.87 (0.65–1.17) 1.12 (0.84–1.49) Current wheeze 1.00 0.96 (0.57–1.62) 0.79 (0.49–1.27) 1.03 (0.65–1.63) Nocturnal wheeze# 1.00 0.62 (0.28–1.36) 0.84 (0.45–1.58) 1.19 (0.65–2.16) Exercise wheeze 1.00 1.27 (0.75–2.14) 1.67 (1.06–2.62) 1.68 (1.07–2.66) Mutually adjusted model¶ Asthma Lifetime asthma 1.00 1.14 (0.76–1.70) 0.99 (0.68–1.44) 1.25 (0.87–1.81) Current asthma# 1.00 1.40 (0.76–2.57) 1.36 (0.77–2.40) 1.92 (1.11–3.32) Medication use 1.00 1.32 (0.62–2.79) 1.42 (0.71–2.85) 2.12 (1.09–4.12) Wheeze Lifetime wheeze 1.00 1.08 (0.77–1.50) 1.02 (0.75–1.39) 1.27 (0.94–1.72) Current wheeze# 1.00 1.02 (0.59–1.76) 0.96 (0.58–1.60) 1.20 (0.73–1.97) Nocturnal wheeze# 1.00 0.65 (0.29–1.45) 0.87 (0.44–1.70) 1.30 (0.69–2.46) Exercise wheeze 1.00 1.33 (0.77–2.28) 1.89 (1.17–3.05) 1.91 (1.18–3.09) Data are presented as odds ratios with 95% confidence intervals. #: significant interaction; ¶: models are adjusted for age, sex, parental education, parental asthma, parental atopy, gestational age, city, maternal smoking during pregnancy and environmental tobacco smoke at home.
- Table 4– Association of frequency of incense burning at home on subcategories of asthma and wheeze by GSTT1 genotype
GSTT1 present GSTT1 null Subjects n 1937 1801 Frequency of incense burning# Asthma Lifetime asthma Never 1.00 1.00 Less than daily 0.74 (0.45–1.21) 0.74 (0.45–1.22) Daily 1.04 (0.66–1.63) 1.42 (0.94–2.13) p-value for trend¶ 0.87 0.09 Current asthma Never 1.00 1.00 Less than daily 1.22 (0.60–2.50) 1.05 (0.54–2.05) Daily 1.37 (0.69–2.75) 1.78 (1.01–3.16) p-value for trend¶ 0.37 0.04 Medication use Never 1.00 1.00 Less than daily 1.22 (0.51–2.92) 1.35 (0.60–3.00) Daily 1.37 (0.59–3.18) 2.26 (1.11–4.57) p-value for trend¶ 0.47 0.02 Wheeze Lifetime wheeze Never 1.00 1.00 Less than daily 0.96 (0.65–1.41) 0.85 (0.57–1.26) Daily 1.02 (0.70–1.49) 1.40 (1.00–1.98) p-value for trend¶ 0.91 0.04 Current wheeze Never 1.00 1.00 Less than daily 0.78 (0.40–1.50) 1.15 (0.62–2.14) Daily 1.01 (0.55–1.87) 1.17 (0.65–2.11) p-value for trend¶ 0.97 0.60 Nocturnal wheeze Never 1.00 1.00 Less than daily 0.86 (0.38–1.96) 1.20 (0.45–3.23) Daily 0.85 (0.37–1.95) 3.21 (1.41–7.30) p-value for trend¶ 0.69 0.003 Exercise wheeze Never 1.00 1.00 Less than daily 2.03 (1.16–3.54) 1.28 (0.71–2.31) Daily 1.86 (1.06–3.28) 1.99 (1.18–3.35) p-value for trend¶ 0.04 0.01 Data are presented as odds ratios with 95% confidence intervals, unless otherwise stated. Models are adjusted for age, sex, parental education, parental asthma, parental atopy, gestational age, city, maternal smoking during pregnancy and environmental tobacco smoke at home. #: average days of incense burning at home per month; ¶: calculated by stratification with GSTT1 genotype.
Additional Files
Supplementary material
Files in this Data Supplement:
- Supplementary tables - Tables S1-S2